TAS-116 Plus Palbociclib in Breast and Rb-null Cancer

Conditions:   Advanced Breast Cancer;   Treatment-Refractory Solid Tumors;   Retinoblastoma Deficiency;   SCLC;   Soft Tissue Sarcoma;   Endometrial Cancer;   Bladder Cancer Interventions:   Drug: Palbociclib Oral Product;   Drug: TAS-116 Sponsors:   Brown University;   Taiho Oncology, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials